 | • レポートコード：QYR9ST04851 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、高齢者用医薬品の世界市場について調査・分析し、高齢者用医薬品の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（鎮痛薬、抗高血圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）、用途別（心血管疾患、関節炎、神経障害、癌、骨粗鬆症、呼吸器）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の高齢者用医薬品市場動向 ・主要企業別マーケットシェア ・高齢者用医薬品の種類別市場規模2014-2019 （鎮痛薬、抗高血圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬） ・高齢者用医薬品の用途別市場規模2014-2019 （心血管疾患、関節炎、神経障害、癌、骨粗鬆症、呼吸器） ・高齢者用医薬品の北米市場：主要企業・種類別/用途別市場規模 ・高齢者用医薬品のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・高齢者用医薬品の中国市場：主要企業・種類別/用途別市場規模 ・高齢者用医薬品の日本国内市場：主要企業・種類別/用途別市場規模 ・高齢者用医薬品の東南アジア市場：主要企業・種類別/用途別市場規模 ・高齢者用医薬品のインド市場：主要企業・種類別/用途別市場規模 ・高齢者用医薬品の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eli Lilly and Company、AstraZeneca、Boehringer Ingelheim、Abbott Laboratories、Sanofi、Bristol-Myers Squibb、Merck、Novartis、Pfizer、GSK） ・高齢者用医薬品の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.In 2018, the global Geriatric Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Geriatric Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Geriatric Medicines development in United States, Europe and China.
The key players covered in this study
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Market segment by Type, the product can be split into
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Market segment by Application, split into
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Geriatric Medicines status, future forecast, growth opportunity, key market and key players.
To present the Geriatric Medicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Geriatric Medicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Geriatric Medicines Market Size Growth Rate by Type (2014-2025)
1.4.2 Analgesics
1.4.3 Antihypertensives
1.4.4 Statins
1.4.5 Antidiabetics
1.4.6 Proton Pump Inhibitor
1.4.7 Anticoagulant
1.4.8 Antipsychotics
1.4.9 Antidepressants
1.5 Market by Application
1.5.1 Global Geriatric Medicines Market Share by Application (2014-2025)
1.5.2 Cardiovascular diseases
1.5.3 Arthritis
1.5.4 Neurological Disorders
1.5.5 Cancer
1.5.6 Osteoporosis
1.5.7 Respiratory
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Geriatric Medicines Market Size
2.2 Geriatric Medicines Growth Trends by Regions
2.2.1 Geriatric Medicines Market Size by Regions (2014-2025)
2.2.2 Geriatric Medicines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Geriatric Medicines Market Size by Manufacturers
3.1.1 Global Geriatric Medicines Revenue by Manufacturers (2014-2019)
3.1.2 Global Geriatric Medicines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI)
3.2 Geriatric Medicines Key Players Head office and Area Served
3.3 Key Players Geriatric Medicines Product/Solution/Service
3.4 Date of Enter into Geriatric Medicines Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Geriatric Medicines Market Size by Type (2014-2019)
4.2 Global Geriatric Medicines Market Size by Application (2014-2019)
5 United States
5.1 United States Geriatric Medicines Market Size (2014-2019)
5.2 Geriatric Medicines Key Players in United States
5.3 United States Geriatric Medicines Market Size by Type
5.4 United States Geriatric Medicines Market Size by Application
6 Europe
6.1 Europe Geriatric Medicines Market Size (2014-2019)
6.2 Geriatric Medicines Key Players in Europe
6.3 Europe Geriatric Medicines Market Size by Type
6.4 Europe Geriatric Medicines Market Size by Application
7 China
7.1 China Geriatric Medicines Market Size (2014-2019)
7.2 Geriatric Medicines Key Players in China
7.3 China Geriatric Medicines Market Size by Type
7.4 China Geriatric Medicines Market Size by Application
8 Japan
8.1 Japan Geriatric Medicines Market Size (2014-2019)
8.2 Geriatric Medicines Key Players in Japan
8.3 Japan Geriatric Medicines Market Size by Type
8.4 Japan Geriatric Medicines Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Geriatric Medicines Market Size (2014-2019)
9.2 Geriatric Medicines Key Players in Southeast Asia
9.3 Southeast Asia Geriatric Medicines Market Size by Type
9.4 Southeast Asia Geriatric Medicines Market Size by Application
10 India
10.1 India Geriatric Medicines Market Size (2014-2019)
10.2 Geriatric Medicines Key Players in India
10.3 India Geriatric Medicines Market Size by Type
10.4 India Geriatric Medicines Market Size by Application
11 Central & South America
11.1 Central & South America Geriatric Medicines Market Size (2014-2019)
11.2 Geriatric Medicines Key Players in Central & South America
11.3 Central & South America Geriatric Medicines Market Size by Type
11.4 Central & South America Geriatric Medicines Market Size by Application
12 International Players Profiles
12.1 Eli Lilly and Company
12.1.1 Eli Lilly and Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Geriatric Medicines Introduction
12.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2014-2019)
12.1.5 Eli Lilly and Company Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Company Details
12.2.2 Company Description and Business Overview
12.2.3 Geriatric Medicines Introduction
12.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2014-2019)
12.2.5 AstraZeneca Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Details
12.3.2 Company Description and Business Overview
12.3.3 Geriatric Medicines Introduction
12.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2014-2019)
12.3.5 Boehringer Ingelheim Recent Development
12.4 Abbott Laboratories
12.4.1 Abbott Laboratories Company Details
12.4.2 Company Description and Business Overview
12.4.3 Geriatric Medicines Introduction
12.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2014-2019)
12.4.5 Abbott Laboratories Recent Development
12.5 Sanofi
12.5.1 Sanofi Company Details
12.5.2 Company Description and Business Overview
12.5.3 Geriatric Medicines Introduction
12.5.4 Sanofi Revenue in Geriatric Medicines Business (2014-2019)
12.5.5 Sanofi Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Company Details
12.6.2 Company Description and Business Overview
12.6.3 Geriatric Medicines Introduction
12.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2014-2019)
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Geriatric Medicines Introduction
12.7.4 Merck Revenue in Geriatric Medicines Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Geriatric Medicines Introduction
12.8.4 Novartis Revenue in Geriatric Medicines Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Geriatric Medicines Introduction
12.9.4 Pfizer Revenue in Geriatric Medicines Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 GSK
12.10.1 GSK Company Details
12.10.2 Company Description and Business Overview
12.10.3 Geriatric Medicines Introduction
12.10.4 GSK Revenue in Geriatric Medicines Business (2014-2019)
12.10.5 GSK Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Geriatric Medicines Key Market Segments
Table Key Players Geriatric Medicines Covered
Table Global Geriatric Medicines Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Geriatric Medicines Market Size Market Share by Type 2014-2025
Figure Analgesics Figures
Table Key Players of Analgesics
Figure Antihypertensives Figures
Table Key Players of Antihypertensives
Figure Statins Figures
Table Key Players of Statins
Figure Antidiabetics Figures
Table Key Players of Antidiabetics
Figure Proton Pump Inhibitor Figures
Table Key Players of Proton Pump Inhibitor
Figure Anticoagulant Figures
Table Key Players of Anticoagulant
Figure Antipsychotics Figures
Table Key Players of Antipsychotics
Figure Antidepressants Figures
Table Key Players of Antidepressants
Table Global Geriatric Medicines Market Size Growth by Application 2014-2025 (Million US$)
Figure Cardiovascular diseases Case Studies
Figure Arthritis Case Studies
Figure Neurological Disorders Case Studies
Figure Cancer Case Studies
Figure Osteoporosis Case Studies
Figure Respiratory Case Studies
Figure Geriatric Medicines Report Years Considered
Table Global Geriatric Medicines Market Size 2014-2025 (Million US$)
Figure Global Geriatric Medicines Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Geriatric Medicines Market Size by Regions 2014-2025 (Million US$)
Table Global Geriatric Medicines Market Size by Regions 2014-2019 (Million US$)
Table Global Geriatric Medicines Market Share by Regions 2014-2019
Figure Global Geriatric Medicines Market Share by Regions 2014-2019
Figure Global Geriatric Medicines Market Share by Regions 2019
Table Market Top Trends
Table Global Geriatric Medicines Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Geriatric Medicines Market Share by Manufacturers (2014-2019)
Figure Global Geriatric Medicines Market Share by Manufacturers in 2018
Table Global Geriatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Geriatric Medicines Product/Solution/Service
Table Date of Enter into Geriatric Medicines Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table Global Geriatric Medicines Market Size Share by Type (2014-2019)
Figure Global Geriatric Medicines Market Size Market Share by Type (2014-2019)
Table Global Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table Global Geriatric Medicines Market Size Share by Application (2014-2019)
Figure Global Geriatric Medicines Market Size Market Share by Application (2014-2019)
Figure Global Geriatric Medicines Revenue Market Share by Application in 2018
Figure United States Geriatric Medicines Market Size 2014-2019 (Million US$)
Table United States Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table United States Key Players Geriatric Medicines Market Share (2018-2019)
Table United States Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table United States Geriatric Medicines Market Share by Type (2014-2019)
Table United States Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table United States Geriatric Medicines Market Share by Application (2014-2019)
Figure Europe Geriatric Medicines Market Size 2014-2019 (Million US$)
Table Europe Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table Europe Key Players Geriatric Medicines Market Share (2018-2019)
Table Europe Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table Europe Geriatric Medicines Market Share by Type (2014-2019)
Table Europe Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table Europe Geriatric Medicines Market Share by Application (2014-2019)
Figure China Geriatric Medicines Market Size 2014-2019 (Million US$)
Table China Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table China Key Players Geriatric Medicines Market Share (2018-2019)
Table China Geriatric Medicines Market Size by Type (2014-20189) (Million US$)
Table China Geriatric Medicines Market Share by Type (2014-2019)
Table China Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table China Geriatric Medicines Market Share by Application (2014-2019)
Figure Japan Geriatric Medicines Market Size 2014-2019 (Million US$)
Table Japan Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table Japan Key Players Geriatric Medicines Market Share (2018-2019)
Table Japan Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table Japan Geriatric Medicines Market Share by Type (2014-2019)
Table Japan Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table Japan Geriatric Medicines Market Share by Application (2014-2019)
Figure Southeast Asia Geriatric Medicines Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Geriatric Medicines Market Share (2018-2019)
Table Southeast Asia Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Geriatric Medicines Market Share by Type (2014-2019)
Table Southeast Asia Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Geriatric Medicines Market Share by Application (2014-2019)
Figure India Geriatric Medicines Market Size 2014-2019 (Million US$)
Table India Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table India Key Players Geriatric Medicines Market Share (2018-2019)
Table India Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table India Geriatric Medicines Market Share by Type (2014-2019)
Table India Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table India Geriatric Medicines Market Share by Application (2014-2019)
Figure Central & South America Geriatric Medicines Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Geriatric Medicines Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Geriatric Medicines Market Share (2018-2019)
Table Central & South America Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Table Central & South America Geriatric Medicines Market Share by Type (2014-2019)
Table Central & South America Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Table Central & South America Geriatric Medicines Market Share by Application (2014-2019)
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Geriatric Medicines Business (2014-2019) (Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table AstraZeneca Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Merck Company Details
Table Merck Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table Pfizer Recent Development
Table GSK Company Details
Table GSK Revenue in Geriatric Medicines Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Geriatric Medicines Business (2014-2019)
Table GSK Recent Development
Table Global Geriatric Medicines Market Size by Regions (Million US$) 2019-2025
Figure Global Geriatric Medicines Market Size Share by Regions (2019-2025)
Figure Global Geriatric Medicines Market Size Share by Regions in 2025
Figure United States Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Figure Europe Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Figure China Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Figure Japan Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Figure India Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Geriatric Medicines Market Size Forecast (2019-2025)(Million USD)
Table Global Geriatric Medicines Market Size by Product (2019-2025) (Million US$)
Figure Global Geriatric Medicines Market Size by Product (2019-2025)
Figure Global Geriatric Medicines Market Size by Product in 2025
Table Global Geriatric Medicines Market Size by Application (2019-2025) (Million US$)
Figure Global Geriatric Medicines Market Size by Application (2019-2025)
Figure Global Geriatric Medicines Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
代替薬及び療法の世界市場：市場規模・現状・予測 Medicines which are used as an alternative or considered complementary medicinal treatment to a conventional medical treatment are known as alternative medicines. It is a natural method of treatment which excludes usual methodology of allopathy. This type of treatment is not a part of the study prog…- 小児薬の世界市場：インサイト・予測 The pediatric drug market plays a pivotal role in the pharmaceutical industry.The pediatric medicines market identifies the formulatory advancement as one of the primary factors for this market’s growth. The global Pediatric Medicines market is valued at xx million US$ in 2018 and will reach xx mill…
- 世界の麻酔薬市場：専門的調査 Anesthesia or anaesthesia is a state of controlled, temporary loss of sensation or awareness that is induced for medical purposes. It may include analgesia, paralysis, amnesia, or unconsciousness. A patient under the effects of anesthetic drugs is referred to as being anesthetized. The global Anaest…
- 世界のアーユルヴェーダダイエット及び薬市場：専門的調査 In Ayurvedic preparations, the part of an herb is chosen and used depending on where its medicinal value lies and its curative effects on the body. The global Ayurvedic Diet and Medicines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR …
- 世界の診断核医学市場：専門的調査 Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis The global Diagnostic Nuclear Medicines market was valued at xx million …